---
layout: home
---

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>CDK Inhibitors in Cancer Treatment</title>
  <link href="https://fonts.googleapis.com/css2?family=Lora:wght@400;600&display=swap" rel="stylesheet">
<style>
  /* General Styles */
  body {
    font-family: 'Lora', serif;
    margin: 0;
    padding: 0;
    line-height: 1.6;
    color: #333;
    background-color: #f9f9f9;
  }

  h1, h2, h3 {
    color: #2c3e50;
    margin-top: 20px;
  }

  h1 {
    text-align: center;
    font-size: 2.5rem;
    margin-bottom: 10px;
  }

  h2 {
    text-align: center;
    font-size: 1.75rem;
    margin-bottom: 20px;
  }

  p {
    margin: 10px 0;
  }

  a {
    text-decoration: none;
    color: #3498db;
    transition: color 0.3s ease-in-out;
  }

  a:hover {
    color: #f1c40f;
  }

  /* Sidebar Styling */
  .sidenav {
    height: 100%;
    width: 18%;
    position: fixed;
    top: 0;
    left: 0;
    background-color: #2c3e50;
    overflow-x: hidden;
    padding-top: 20px;
    z-index: 100000;
    color: #ecf0f1;
  }

  .sidenav .header {
    font-size: 24px;
    color: #f1c40f;
    text-align: center;
    margin-bottom: 20px;
    font-weight: bold;
  }

  .sidenav a {
    padding: 10px 20px;
    display: block;
    color: #ecf0f1;
    transition: 0.3s;
  }

  .sidenav a:hover {
    background-color: #34495e;
    color: #f1c40f;
    padding-left: 25px;
  }

  .sidenav .submenu a {
    padding-left: 30px;
  }

  /* Content Styling */
  .content {
    margin-left: 6%; /* Ensure content is correctly offset from sidebar */
    padding: 20px;
    width: 70%; /* Adjust width to account for sidebar */
    background-color: #ffffff;
    box-shadow: 0 4px 8px rgba(0, 0, 0, 0.1);
    border-radius: 8px;
    margin: 20px auto; /* Center horizontally and add vertical spacing */
  }

  .content-section {
    margin-bottom: 20px;
  }

  .image-placeholder {
    background-color: #bdc3c7;
    height: 150px;
    margin: 10px 0;
    text-align: center;
    line-height: 150px;
    color: #fff;
    border-radius: 4px;
  }

  /* Title Styling */
  .title-container {
    text-align: center;
    padding: 20px 0;
    margin-bottom: 20px;
    background-color: #2c3e50; /* Dark blue */
    color: #ffffff; /* White text for better contrast */
    border-radius: 8px;
  }

  .title-container h1 {
    margin: 0;
    font-size: 2.2rem;
    color: #ecf0f1; /* Light gray for better readability */
  }

  .title-container h2 {
    margin: 5px 0 0;
    font-size: 1.5rem;
    color: #f1c40f; /* Yellow accent */
  }
</style>
</head>
<body>
  <!-- Sidebar -->
  <div class="sidenav">
    <a href="#introduction">Introduction</a>
    <a href="#cell-cycle">Cell Cycle Overview</a>
    <div class="submenu">
      <a href="#enzymes">CDKs & Cyclins</a>
      <a href="#disruption">Targeting CDK</a>
    </div>
    <a href="#research-question">Research Question</a>
    <a href="#study-cdks">Study of CDKs</a>
    <div class="submenu">
      <a href="#dna-sequence">DNA Sequence Similarities</a>
      <a href="#visual-rep">Visual Representations</a>
    </div>
    <a href="#study-ligands">Study of Ligands</a>
    <div class="submenu">
      <a href="#affinity-patterns">Affinity Patterns</a>
      <a href="#ligand-visuals">Ligand Visuals</a>
    </div>
  </div>

  <!-- Main Content -->
  <div class="content">
    <!-- Title Section -->
    <div class="title-container">
      <h1>CDK Inhibitors in Cancer Treatment</h1>
      <h2>Exploring the Role of CDKs in Cell Proliferation</h2>
    </div>

    <!-- Introduction -->
    <div id="introduction" class="content-section">
      <h1>Introduction</h1>
      <p>Globally, 1 in 6 people die from cancer. Despite their differences, all cancers share a common hallmark: uncontrolled cell proliferation. But what exactly is cell proliferation?</p>

      <p>In healthy cells, division occurs through mitosis, producing two new cells in a tightly regulated process known as the cell cycle. This cycle involves a series of intricate biochemical reactions. In cancer cells, however, the cell cycle becomes abnormally fast and uncontrolled, leading to the formation of a mass of cells known as a tumor.</p>
        
      <p>But what if we could disrupt this cycle and halt cell proliferation in cancer patients?</p>
        
      <p>To explore this possibility, we need to delve deeper into the cell cycle. It consists of four distinct phases, each governed by specific enzymes, the main ones being the cyclin-dependent kinases (CDKs). For instance, CDK2, when bound to cyclin B, activates it and ensures the transition from the S phase to the G2 phase of the cycle.</p>
        
      <p>Could we find inhibitors that could target the CDKs/cyclin complex and therefore reduce the catalytic activity of  involved in this anarchic cell proliferation? Find molecules that could bind to a CDKs, therefore reducing its catalytic activity.</p>

    <!-- Cell Cycle Overview -->
    <div id="cell-cycle" class="content-section">
      <h2>Cell Cycle Overview</h2>
      <p>The cell cycle consists of four distinct phases, each governed by specific enzymes. The main ones are the <strong>cyclin-dependent kinases (CDKs)</strong>. For example, CDK2, when bound to cyclin B, ensures the transition from the S phase to the G2 phase of the cycle.</p>
    </div>

    <!-- CDKs and Cyclins -->
    <div id="enzymes" class="content-section">
      <h3>CDKs and Cyclins</h3>
      <p>CDKs are critical regulators of the cell cycle. Disrupting the CDK/cyclin complex can potentially halt uncontrolled proliferation.</p>
    </div>

    <!-- Research Question -->
    <div id="research-question" class="content-section">
      <h2>Research Question</h2>
      <p>Could we find potential inhibitors of CDK activity from new ligands using BindingDB?</p>
    </div>

    <!-- Ligands -->
    <div id="study-ligands" class="content-section">
      <h2>Study of Ligands</h2>
      <p>We now study the ligands that bind to CDKs. Do ligands with high affinity share structural patterns?</p>
    </div>
  </div>
</body>
</html>
